Sonic Healthcare: Initiation of Coverage- Inside the FY ‘26 Ramp-Up That Could Up Its Diagnostics Game!

Sonic Healthcare’s latest half-year financial results for the period ending December 31, 2024, provide a comprehensive overview of the company’s recovery and growth trajectory in the post-pandemic world. The company has displayed a substantial rebound, with significant improvement across key financial metrics, guided by strong organic growth and tight cost control measures, particularly in labor costs. Revenue for the period was reported at AUD 4.669 billion, an 8% increase compared to the previous period. EBITDA grew by 12% to AUD 827 million, while net profit experienced a notable rise of 17% to AUD 237 million. Cash generation from operations was also strong, up 37% to AUD 620 million. Earnings per share increased by 15% to AUD 0.492. The company maintained its full-year guidance with a projected EBITDA of AUD 1.7 billion to AUD 1.75 billion, emphasizing continued steady performance.